Stock Analysis, Dividends, Split History

ENDV / Endonovo Therapeutics, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)21.89
Enterprise Value ($M)29.32
Book Value ($M)-9.12
Book Value / Share-0.02
Price / Book-2.40
NCAV ($M)-13.30
NCAV / Share-0.04
Price / NCAV-1.65
Share Statistics
Common Shares Outstanding 341,345,596
Convertible Preferred Stock Shares Outstanding 0
Preferred Stock Shares Outstanding 5,000
Common Stock Shares Outstanding 316,951,712
Scoring Models
Piotroski F-Score1.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)4.94
Return on Assets (ROA)-33.92
Return on Equity (ROE)1.26
Balance Sheet (mrq) ($M)
Quick Ration/a
Current Ratio0.01
Income Statement (mra) ($M)
Sales Revenue Net0.00
Operating Income-4.60
Net Income-10.81
Earnings Per Share Basic-0.04
Earnings Per Share Basic And Diluted-0.04
Earnings Per Share Diluted-0.04
Cash Flow Statement (mra) ($M)
Cash From Operations-2.99
Cash from Investing-3.00
Cash from Financing-3.00
Identifiers and Descriptors
Central Index Key (CIK)1528172

Split History

Stock splits are used by Endonovo Therapeutics, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon
CUSIP: 29272H102